Feasibility and Clinical Utility of Ambulatory Ultraslow Deflation Sphygmomanometers in LVAD Recipients - easiSLOW-LVAD Pilot

Starting soon · Not applicable

Conditions studied: LVAD (Left Ventricular Assist Device)

In brief

Prospective, single-arm feasibility study will evaluate the use of an ultraslow deflation automated sphygmomanometer (Terumo Elemano 2) for home BP monitoring in patients with continuous-flow LVADs. Outcomes include patient-reported ability to obtain BP readings, adherence, ease of use, and correlation with clinical parameters. Findings may support improved BP monitoring strategies in this high-risk population.

Key facts

Study ID

NCT07633561

Run by

University of Florida

People needed

50

Starts

2026-08-01

Expected to finish

2028-02-01

Last updated by the study team

2026-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HM3 LVAD and age > 18

You may not qualify if…

• eGFR < 30
• bilateral limb alerts (inability to obtain upper extremity blood pressures)
• ongoing inotropic support
• cognitive or severe visual impairment
• the use of an investigational LVAD
• Durable biventricular support

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.